Australia markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
16.68-0.07 (-0.42%)
As of 11:58AM EST. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 553.49B
Enterprise value 352.37B
Trailing P/E 20.55
Forward P/E 119.40
PEG ratio (5-yr expected) 14,215.10
Price/sales (ttm)N/A
Price/book (mrq)1.33
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) 1.11
52-week change 3-3.18%
S&P500 52-week change 323.92%
52-week high 320.00
52-week low 312.43
50-day moving average 317.64
200-day moving average 317.85

Share statistics

Avg vol (3-month) 33.51M
Avg vol (10-day) 34.17M
Shares outstanding 53.15B
Float 3.13B
% held by insiders 10.00%
% held by institutions 13.50%
Shares short (11 Feb 2021) 45.88M
Short ratio (11 Feb 2021) 41.13
Short % of float (11 Feb 2021) 4N/A
Short % of shares outstanding (11 Feb 2021) 40.19%
Shares short (prior month 14 Jan 2021) 47.77M

Dividends & splits

Forward annual dividend rate 40.85
Forward annual dividend yield 45.07%
Trailing annual dividend rate 31.63
Trailing annual dividend yield 39.76%
5-year average dividend yield 43.94
Payout ratio 4158.19%
Dividend date 314 Dec 2009
Ex-dividend date 428 Sep 2020
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin 5.65%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)1.41%
Return on equity (ttm)3.80%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)-2.60%
Gross profit (ttm)2.2T
Net income avi to common (ttm)N/A
Diluted EPS (ttm)0.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)113.08
Current ratio (mrq)1.45
Book value per share (mrq)12.55

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A